casodex 150 mg filmdragerad tablett
teva sweden ab - bikalutamid - filmdragerad tablett - 150 mg - bikalutamid 150 mg aktiv substans; laktosmonohydrat hjälpämne - bikalutamid
casodex 150 mg filmdragerad tablett
parallell pharma ab - bikalutamid - filmdragerad tablett - 150 mg - bikalutamid 150 mg aktiv substans; laktosmonohydrat hjälpämne - bikalutamid
casodex 150 mg filmdragerad tablett
qdoxx pharma ab - bikalutamid - filmdragerad tablett - 150 mg - bikalutamid 150 mg aktiv substans; laktosmonohydrat hjälpämne - bikalutamid
bicalutamide bluefish 150 mg filmdragerad tablett
bluefish pharmaceuticals ab - bikalutamid - filmdragerad tablett - 150 mg - propylenglykol hjälpämne; laktosmonohydrat hjälpämne; bikalutamid 150 mg aktiv substans - bikalutamid
bicalutamid sandoz 150 mg filmdragerad tablett
sandoz a/s - bikalutamid - filmdragerad tablett - 150 mg - laktosmonohydrat hjälpämne; bikalutamid 150 mg aktiv substans - bikalutamid
verzenios
eli lilly nederland b.v. - abemaciclib - bröst-neoplasmer - antineoplastiska medel - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
casodex 150 mg filmdragerad tablett
orifarm ab - bikalutamid - filmdragerad tablett - 150 mg - bikalutamid 150 mg aktiv substans; laktosmonohydrat hjälpämne
bicalutamide teva 150 mg filmdragerad tablett
teva sweden ab - bikalutamid - filmdragerad tablett - 150 mg - laktosmonohydrat hjälpämne; bikalutamid 150 mg aktiv substans; natriumlaurilsulfat hjälpämne - bikalutamid
myocrisin 100 mg/ml injektionsvätska, lösning
sanofi ab - natriumaurotiomalat - injektionsvätska, lösning - 100 mg/ml - natriumaurotiomalat 100 mg aktiv substans; fenylkvicksilvernitrat hjälpämne - natriumaurotiomalat
montelukast teva 10 mg filmdragerad tablett
teva sweden ab - montelukastnatrium - filmdragerad tablett - 10 mg - montelukastnatrium 10,4 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne - montelukast